---
title: "IF 12.8！单细胞＋空间转录揭示：COL10A1⁺成纤维细胞通过CD18/JAK1/STAT3轴驱动M2巨噬细胞极化的新机制"
date: 2026-02-12T16:02:37Z
draft: ["false"]
tags: [
  "fetched",
  "生信图Bioinfo"
]
categories: ["Acdemic"]
---
IF 12.8！单细胞＋空间转录揭示：COL10A1⁺成纤维细胞通过CD18/JAK1/STAT3轴驱动M2巨噬细胞极化的新机制 by 生信图Bioinfo
------
<div><h1 data-tool="mdnice编辑器" data-pm-slice="0 0 []"><span><span leaf="">文献学习</span></span></h1><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100001755" data-ratio="0.48722627737226276" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/Eia2ZkbFE3ImSoQ9gzCpkvG8ia3GGiaapM7ELJ7e1uibR4pErtaribca8ODvc6A321QsCN6LWTMY0tVviaQVVdIVO9dST0ow8qeelU4R5ehWPq0ibk/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1096" type="block" src="https://mmbiz.qpic.cn/sz_mmbiz_png/Eia2ZkbFE3ImSoQ9gzCpkvG8ia3GGiaapM7ELJ7e1uibR4pErtaribca8ODvc6A321QsCN6LWTMY0tVviaQVVdIVO9dST0ow8qeelU4R5ehWPq0ibk/640?wx_fmt=png&amp;from=appmsg"></section><p data-pm-slice="0 0 []"><span><font face="Segoe UI"><span leaf=""><span textstyle="">本次分享的文献是由北京大学医学部医学技术研究院在</span><span textstyle="">《</span></span></font><span leaf=""><span textstyle="">Journal of Experimental &amp; Clinical Cancer Research</span></span><font face="Segoe UI"><span leaf=""><span textstyle="">》（中科院1区Top，IF=12.8）</span><span textstyle="">上发表了题为</span><span textstyle="">“</span></span><span leaf=""><span textstyle="">COL10A1⁺ fibroblasts promote colorectal cancer metastasis and M2 macrophage polarization with pan-cancer relevance</span></span><span leaf=""><span textstyle="">”</span><span textstyle="">的研究论文，</span></span><span data-pm-slice="0 0 []"><span leaf="">本研究通过整合多组学数据（单细胞、批量RNA-seq、空间转录组、蛋白质组）结合体内外实验，识别并表征了一个新型的癌症相关成纤维细胞（CAF）亚群——</span></span><strong><span leaf="">COL10A1⁺ Fibroblasts（COL10A1⁺ Fib）</span></strong><span><span leaf="">。该亚群在结直肠癌（CRC）中富集于晚期阶段，与患者不良预后相关，并通过分泌COL10A1蛋白促进肿瘤细胞上皮-间质转化（EMT）和M2巨噬细胞极化，形成促肿瘤免疫抑制微环境。研究还发现小分子抑制剂</span></span><strong><span leaf="">NU7441</span></strong><span><span leaf="">可抑制COL10A1⁺ Fib的功能，并在泛癌分析中提示该亚群在多种实体瘤中具有类似作用。</span></span></font></span></p><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100001770" data-ratio="0.9194444444444444" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3IkfVfDR1gWc9c7kPMDjgSDnsc5zSmVuH1q1ry4PR88D1pucakZ11FtyTPNVI5UxOzHiccoOkLPeB2mq6095gWWiaszqCN3BXzxb4/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1440" type="block" src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3IkfVfDR1gWc9c7kPMDjgSDnsc5zSmVuH1q1ry4PR88D1pucakZ11FtyTPNVI5UxOzHiccoOkLPeB2mq6095gWWiaszqCN3BXzxb4/640?wx_fmt=png&amp;from=appmsg"></section><h2 data-tool="mdnice编辑器"><span><span leaf="">研究背景</span></span></h2><section><span leaf=""><span textstyle="">结直肠癌是高发胃肠道恶性肿瘤，存在治疗响应差、转移风险高的临床问题，肿瘤相关成纤维细胞（CAFs）是肿瘤微环境核心基质细胞，参与肿瘤发生发展，但</span></span><strong data-pm-slice="0 0 []"><span leaf=""><span textstyle="">其功能异质性尚未被充分解析</span></span></strong><span leaf=""><span textstyle="">，结直肠癌中CAFs亚型的系统分类和作用机制也缺乏深入研究。COL10A1在多种肿瘤基质中异常上调，与肿瘤转移、不良预后相关，然而其在结直肠癌肿瘤微环境中的</span></span><strong><span leaf=""><span textstyle="">细胞来源、调控网络及成药性</span></span></strong><span leaf=""><span textstyle="">均未明确，亟需开展针对性研究以挖掘潜在治疗靶点</span></span></section><section><span><span leaf="">研究数据</span></span></section><p><span leaf=""><span textstyle="">结直肠癌相关样本：</span><span textstyle="">3395 个，包括 3122 个 bulk RNA-seq、234 个单细胞 RNA-seq、4 个空间转录组；</span></span></p><p><span leaf=""><span textstyle="">其他实体瘤样本：</span><span textstyle="">6769 个，包括 6636 个 bulk RNA-seq、125 个单细胞 RNA-seq、8 个空间转录组；</span></span></p><p><span leaf=""><span textstyle="">临床样本：</span><span textstyle="">35 对结直肠癌肿瘤 / 癌旁配对组织，用于蛋白质水平验证；</span></span></p><p><span leaf=""><span textstyle="">其他数据集：</span><span textstyle="">7 个小鼠单细胞 RNA-seq 数据集、10 个结直肠癌肝转移单细胞数据集，用于跨物种验证和转移相关分析。</span></span></p><section><span><span leaf="">研究方法</span></span></section><p><span leaf=""><span textstyle="">1.样本与数据收集</span></span></p><ul><li><p><span leaf=""><span textstyle="">临床样本：收集南京医科大学第一附属医院35对结直肠癌肿瘤/癌旁配对组织样本；</span></span></p></li><li><p><span leaf=""><span textstyle="">公共多组学数据：整合TCGA、GTEx、GEO等公共数据库的10164个样本，包括结直肠癌3395个样本及肺、肝、胃等9种高死亡率实体瘤6769个样本，涵盖bulkRNA-seq、单细胞RNA-seq、空间转录组、蛋白质组数据。</span></span></p></li></ul><p><span leaf=""><span textstyle="">2.生信数据分析</span></span></p><ul><li><p><span leaf=""><span textstyle="">BulkRNA-seq：用R包sva做批次校正和归一化，CMScaller进行结直肠癌CMS分子分型；</span></span></p></li><li><p><span leaf=""><span textstyle="">单细胞RNA-seq：用R包Seurat做质控、聚类、降维，harmony校正批次效应，SingleR结合CellMarker2.0进行细胞注释，intercnv区分恶性/非恶性上皮细胞；</span></span></p></li><li><p><span leaf=""><span textstyle="">空间转录组：用Seurat预处理，CellTrek实现单细胞与空间转录组的映射，SpaCET进行恶性细胞鉴定和空间基因评分，SpaGene分析配体-受体空间共定位；</span></span></p></li><li><p><span leaf=""><span textstyle="">功能富集：采用GSVA、GSEA、ssGSEA进行通路富集分析；</span></span></p></li><li><p><span leaf=""><span textstyle="">其他：hdWGCNA构建基因共表达网络，SCENIC预测转录因子，oncoPredict算法进行药物敏感性预测，分子对接和分子动力学模拟分析药物与靶蛋白结合。</span></span></p></li></ul><p><span leaf=""><span textstyle="">3.分子与细胞实验</span></span></p><ul><li><p><span leaf=""><span textstyle="">细胞系构建：构建COL10A1+/-成纤维细胞稳定株；</span></span></p></li><li><p><span leaf=""><span textstyle="">细胞功能实验：共培养体系、CCK-8增殖实验、集落形成实验、Transwell迁移/侵袭实验；</span></span></p></li><li><p><span leaf=""><span textstyle="">分子检测：Westernblot（WB）、免疫荧光（IF）、免疫组化（IHC）、酶联免疫吸附试验（ELISA）、Co-IP（免疫共沉淀）、ChIP-qPCR、RT-qPCR、流式细胞术。</span></span></p></li></ul><p><span leaf=""><span textstyle="">4.动物实验</span></span></p><ul><li><p><span leaf=""><span textstyle="">皮下移植瘤模型：裸鼠皮下接种结直肠癌细胞+成纤维细胞，评估肿瘤生长；</span></span></p></li><li><p><span leaf=""><span textstyle="">脾注射肝转移模型：评估COL10A1+Fib对结直肠癌肝转移的促进作用；</span></span></p></li><li><p><span leaf=""><span textstyle="">药物验证：在动物模型中验证NU7441的抗瘤效果。</span></span></p></li></ul><p><span leaf=""><span textstyle="">5.药物筛选与验证：</span><span textstyle="">通过oncoPredict算法筛选198种药物，结合分子对接、体外细胞实验和体内动物实验验证NU7441对COL10A1+Fib的抑制作用。</span></span></p><section><span><span leaf="">研究结果</span></span></section><ol start="1"><li><p><strong><span leaf="">识别COL10A1⁺ Fib亚群</span></strong><span leaf="">：</span></p></li></ol><ul><li><p><span leaf="">在CRC单细胞数据中鉴定出11个成纤维细胞亚群，其中Fib_1（即COL10A1⁺ Fib）在肿瘤组织中富集，且随TNM分期升高而增加。</span></p></li><li><p><span leaf="">COL10A1⁺ Fib高表达与患者总生存期（OS）和无复发生存期（RFS）缩短显著相关。</span></p></li></ul><li><p><strong><span leaf="">促转移机制</span></strong><span leaf="">：</span></p></li><ul><li><p><span leaf="">COL10A1⁺ Fib通过分泌COL10A1诱导CRC细胞发生EMT（E-cadherin↓, N-cadherin↑, Vimentin↑）。</span></p></li><li><p><span leaf="">空间转录组显示COL10A1⁺ Fib与高恶性上皮亚群（Epi_1）空间相邻，增强其侵袭性。</span></p></li></ul><li><p><strong><span leaf="">免疫抑制机制</span></strong><span leaf="">：</span></p></li><ul><li><p><span leaf="">COL10A1⁺ Fib通过COL10A1/CD18/JAK1/STAT3轴诱导M2巨噬细胞极化（CD163⁺, CD206⁺）。</span></p></li><li><p><span leaf="">M2巨噬细胞通过分泌TGF-β激活RUNX2，进而上调COL10A1表达，形成正反馈环路。</span></p></li></ul><li><p><strong><span leaf="">靶向干预</span></strong><span leaf="">：</span></p></li><ul><li><p><span leaf="">小分子抑制剂NU7441（DNA-PKcs抑制剂）降低COL10A1表达与分泌，抑制CAF活性，逆转EMT与M2极化。</span></p></li><li><p><span leaf="">NU7441在体内外均能抑制肿瘤生长与转移。</span></p></li></ul><li><p><strong><span leaf="">泛癌意义</span></strong><span leaf="">：</span></p></li><ul><li><p><span leaf="">COL10A1⁺ Fib在9种实体瘤中均富集于肿瘤组织，且与免疫抑制、转移相关通路正相关，提示其作为一种保守的促癌基质亚群。</span></p></li></ul><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100001772" data-ratio="1.3285509325681493" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/Eia2ZkbFE3IlTDrLNkG8NCMqrf46aZBBx8MQdtKna2YuHSicxabSfW76r0m2jDcRQxXOKKUer8WOicXyjqC9bOVdBbkOJbmMoo1fPQdaUAIkMQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1394" type="block" src="https://mmbiz.qpic.cn/sz_mmbiz_png/Eia2ZkbFE3IlTDrLNkG8NCMqrf46aZBBx8MQdtKna2YuHSicxabSfW76r0m2jDcRQxXOKKUer8WOicXyjqC9bOVdBbkOJbmMoo1fPQdaUAIkMQ/640?wx_fmt=png&amp;from=appmsg"></section><section><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">图 1：</span><span textstyle=""> 成纤维细胞在晚期CRC中的功能特征鉴定</span></span></span></section><p><span leaf=""><span textstyle="">本研究整合GEO和ArrayExpress的scRNA-seq数据，构建多中心（Merge.ScRNA，n=119）和单中心（ScRNA.GSE178341，n=98）队列，质控后注释7种主要细胞类型，通过细胞通讯分析和GSVA通路富集，探究成纤维细胞在不同TNM分期的功能差异。关键结果：成纤维细胞的细胞间通讯强度仅次于上皮肿瘤细胞，TNMIV期成纤维细胞显著富集EMT、TGF-β信号、缺氧等促转移和免疫抑制通路，且在独立队列中验证。</span></span></p><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100001773" data-ratio="1.2995839112343968" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3ImFjnwSSXzSoDQquZOSyUEfM6ic79gNSE2IUMNgePeSPMWs0phT1v2FxBaXlvAPW47Me5M4Mfq0SAr4sz0dMmNWpz8XD3fxmJLM/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1442" type="block" src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3ImFjnwSSXzSoDQquZOSyUEfM6ic79gNSE2IUMNgePeSPMWs0phT1v2FxBaXlvAPW47Me5M4Mfq0SAr4sz0dMmNWpz8XD3fxmJLM/640?wx_fmt=png&amp;from=appmsg"></section><section><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">图 2： </span><span textstyle="">COL10A1+Fib亚群的鉴定与特征</span></span></span></section><p><span leaf=""><span textstyle="">实验对Merge.ScRNA队列的成纤维细胞重聚类，分析亚群的组织分布、TNM分期相关性、伪时间轨迹，通过hdWGCNA筛选亚群特异性标志物。</span></span></p><p><span leaf=""><span textstyle="">关键结果：得到11个成纤维细胞亚群，Fib_1亚群在肿瘤组织富集且随TNM分期进展比例升高，COL10A1为其特异性标志物（定义为COL10A1+Fib），在晚期CRC和CAFs中高表达。</span></span></p><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100001774" data-ratio="1.15633423180593" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/Eia2ZkbFE3Inqj4UTfN5icByJeyB7hqYKE4K7eblGzWJ9Mo2YT2cMYrgDLBDVXLiaNw7b4taVroY1GQSe4ngicgDGTVIIvzmHtCKk0raYITC18U/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1484" type="block" src="https://mmbiz.qpic.cn/sz_mmbiz_png/Eia2ZkbFE3Inqj4UTfN5icByJeyB7hqYKE4K7eblGzWJ9Mo2YT2cMYrgDLBDVXLiaNw7b4taVroY1GQSe4ngicgDGTVIIvzmHtCKk0raYITC18U/640?wx_fmt=png&amp;from=appmsg"></section><section><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">图 3：</span></span><span leaf=""><span textstyle="">COL10A1+Fib的临床验证与预后价值</span></span></span></section><p><span leaf=""><span textstyle="">实验利用35对CRC临床配对样本，通过WB、IF、IHC验证COL10A1的蛋白表达；结合TCGA和10个GEO数据集（Bulk.GEO.Merge，n=1854），分析COL10A1+Fib浸润与患者OS、RFS的关系。关键结果：COL10A1在肿瘤组织和CAFs中显著高表达且随分期升高，高COL10A1+Fib浸润与患者更差的OS和RFS显著相关（HR分别为5.18和2.59）。</span></span></p><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100001775" data-ratio="1.1184387617765814" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3IkXKdG88EEOkXZP2b7GGa9t7eEOHpSeyzuiciaERJhmyncLMf9aSvibw4WhVbicAsqicicNUicebviaICda9hb46fpxQBpSUe7sB8Ql7O4/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1486" type="block" src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3IkXKdG88EEOkXZP2b7GGa9t7eEOHpSeyzuiciaERJhmyncLMf9aSvibw4WhVbicAsqicicNUicebviaICda9hb46fpxQBpSUe7sB8Ql7O4/640?wx_fmt=png&amp;from=appmsg"></section><section><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">图 4： </span></span><span leaf=""><span textstyle="">COL10A1+Fib对CRC细胞恶性表型的影响</span></span></span></section><p><span leaf=""><span textstyle="">研究构建了COL10A1+/-Fib稳定株，与HCT116、SW620细胞共培养，进行CCK-8、集落形成、Transwell实验；建立裸鼠皮下移植瘤和脾注射肝转移模型。关键结果：COL10A1+Fib显著促进CRC细胞增殖、集落形成、迁移和侵袭，加速皮下肿瘤生长（Ki67表达升高）并增加肝转移灶数量，且作用强于普通CAFs。</span></span></p><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100001776" data-ratio="0.9730820995962315" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3IkKLVwx2jsAtJHRHyLSIuHiauFOuRDL0k3tz92qhgWcdV4YPJ8H9tHo4Gs91gMFhGF1ddhG8QgPYBNNh8GicU1MwEibJ1C6E1icEBw/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1486" type="block" src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3IkKLVwx2jsAtJHRHyLSIuHiauFOuRDL0k3tz92qhgWcdV4YPJ8H9tHo4Gs91gMFhGF1ddhG8QgPYBNNh8GicU1MwEibJ1C6E1icEBw/640?wx_fmt=png&amp;from=appmsg"></section><section><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">图 5：</span></span><span leaf=""><span textstyle="">COL10A1+Fib诱导CRC细胞EMT的机制</span></span></span></section><p><span leaf=""><span textstyle="">该研究分析多组学数据中COL10A1+Fib与EMT评分的相关性；通过WB、IF、IHC检测共培养或rCOL10A1处理后CRC细胞的EMT标志物（E-钙粘蛋白、N-钙粘蛋白、波形蛋白）。关键结果：COL10A1+Fib浸润与EMT评分高度相关（R&gt;0.9），通过分泌COL10A1以剂量依赖方式诱导CRC细胞EMT（下调E-钙粘蛋白，上调N-钙粘蛋白和波形蛋白）。</span></span></p><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100001777" data-ratio="1.2395693135935397" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/Eia2ZkbFE3IkB8gibypVias7oDZql0SMFk4U11RW9mpqGYq70jvPuFNKZiak6YCHfMkEibyYafAprpFqr1oeF6NGo9ma6gRZzh5GLlfX1JnmNiadw/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1486" type="block" src="https://mmbiz.qpic.cn/sz_mmbiz_png/Eia2ZkbFE3IkB8gibypVias7oDZql0SMFk4U11RW9mpqGYq70jvPuFNKZiak6YCHfMkEibyYafAprpFqr1oeF6NGo9ma6gRZzh5GLlfX1JnmNiadw/640?wx_fmt=png&amp;from=appmsg"></section><section><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">图 6：</span></span><span leaf=""><span textstyle="">COL10A1+Fib对M2巨噬细胞极化的诱导作用</span></span></span></section><p><span leaf=""><span textstyle="">研究通过空间转录组和IF分析COL10A1+Fib与巨噬细胞的共定位；qPCR、WB、流式检测共培养后M1（NOS2）和M2（CD163、CD206）标志物表达；rCOL10A1剂量依赖实验验证。关键结果：COL10A1+Fib与M2巨噬细胞（APOE+Macr、SPP1+Macr、C1QA+Macr）空间共定位，特异性上调M2标志物表达，不影响M1标志物，rCOL10A1可模拟该效应。</span></span></p><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100001778" data-ratio="1.4054054054054055" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/Eia2ZkbFE3InFfQpbKv2xdkooVkr0TG2uGYian41dJqvxicW60YicUOPptH75YH1ypdo1NSFdsmTbNAic6NylbV8e6Ax6EpozmVUFrQeUNZMhUSE/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1332" type="block" src="https://mmbiz.qpic.cn/sz_mmbiz_png/Eia2ZkbFE3InFfQpbKv2xdkooVkr0TG2uGYian41dJqvxicW60YicUOPptH75YH1ypdo1NSFdsmTbNAic6NylbV8e6Ax6EpozmVUFrQeUNZMhUSE/640?wx_fmt=png&amp;from=appmsg"></section><section><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">图 7：</span></span><span leaf=""><span textstyle="">COL10A1/CD18/JAK1/STAT3信号轴介导M2极化</span></span></span></section><p><span leaf=""><span textstyle="">实验细胞通讯分析筛选配体-受体对；Co-IP验证COL10A1与CD18的结合；WB检测JAK1/STAT3通路磷酸化水平；siCD18或JAK1/STAT3抑制剂（鲁索利替尼）干预实验。关键结果：COL10A1与巨噬细胞表面CD18直接结合，激活JAK1/STAT3通路（p-JAK1、p-STAT3升高），干预CD18或通路可完全阻断M2极化。</span></span></p><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100001779" data-ratio="0.989247311827957" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/Eia2ZkbFE3InFELUiaUB8qERwCLwOkMC4X1Da225Yc3ZVS4BpMulVa4P3gRZxBw227hkjhsicaXjjPSZLjPNUIcvVCujY78gUpiatXTCNgzpXTU/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1488" type="block" src="https://mmbiz.qpic.cn/sz_mmbiz_png/Eia2ZkbFE3InFELUiaUB8qERwCLwOkMC4X1Da225Yc3ZVS4BpMulVa4P3gRZxBw227hkjhsicaXjjPSZLjPNUIcvVCujY78gUpiatXTCNgzpXTU/640?wx_fmt=png&amp;from=appmsg"></section><section><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">图 8： </span></span><span leaf=""><span textstyle="">TGF-β/RUNX2轴调控COL10A1+Fib的正反馈环路</span></span></span></section><p><span leaf=""><span textstyle="">CENIC预测COL10A1的转录因子；ChIP-qPCR验证RUNX2与COL10A1启动子的结合；WB检测M2巨噬细胞分泌的TGF-β对RUNX2/COL10A1的调控；TGF-β抑制剂（SB-431542）或siRUNX2干预实验。关键结果：RUNX2是COL10A1的关键转录因子，M2巨噬细胞分泌的TGF-β通过激活RUNX2促进COL10A1转录，形成“M2-TGF-β-RUNX2-COL10A1+Fib”正反馈环路。</span></span></p><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100001780" data-ratio="1.3688888888888888" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3InzicQraWPGwQ299Sd6guaOSZHohzIfYD1KheOdo6icIS0WACwlqCEu94Qv6p7XEia8ym63HNjXuVUuqzJGfFX87pICy80DOycsbE/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1350" type="block" src="https://mmbiz.qpic.cn/mmbiz_png/Eia2ZkbFE3InzicQraWPGwQ299Sd6guaOSZHohzIfYD1KheOdo6icIS0WACwlqCEu94Qv6p7XEia8ym63HNjXuVUuqzJGfFX87pICy80DOycsbE/640?wx_fmt=png&amp;from=appmsg"></section><section><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">图 9：</span></span><span leaf=""><span textstyle="">NU7441靶向抑制COL10A1+Fib的功能</span></span></span></section><p><span leaf=""><span textstyle="">oncoPredict算法筛选与COL10A1+Fib负相关的药物；分子对接验证NU7441与COL10A1的结合；WB、ELISA检测NU7441对COL10A1表达/分泌的影响；体外共培养和体内移植瘤模型验证药效。关键结果：NU7441（DNA-PKcs抑制剂）显著抑制COL10A1表达/分泌，阻断Smad2/3磷酸化和RUNX2表达，逆转COL10A1+Fib诱导的CRC细胞增殖、EMT和M2极化，抑制体内肿瘤生长。</span></span></p><section nodeleaf=""><img data-aistatus="1" data-imgfileid="100001781" data-ratio="1.32574679943101" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/Eia2ZkbFE3IncGdjIYvrSFbSzbichdP6JtagFlNBrrs2NzVxHd3eMic6aEsWqVNVsFQoR4TeViaUQYWJUM4Jy6MhldLhVG1SRxVMxwIyhucpHag/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1406" type="block" src="https://mmbiz.qpic.cn/sz_mmbiz_png/Eia2ZkbFE3IncGdjIYvrSFbSzbichdP6JtagFlNBrrs2NzVxHd3eMic6aEsWqVNVsFQoR4TeViaUQYWJUM4Jy6MhldLhVG1SRxVMxwIyhucpHag/640?wx_fmt=png&amp;from=appmsg"></section><section><span data-pm-slice="0 0 []"><span leaf=""><span textstyle="">图 10：</span></span><span leaf=""><span textstyle="">COL10A1+Fib的泛癌分布与保守功能</span></span></span></section><p><span leaf=""><span textstyle="">本研究整合了9种高死亡率实体瘤的多组学数据（bulkRNA-seq、scRNA-seq、空间转录组），分析COL10A1表达、通路富集、免疫浸润及COL10A1+Fib的分布。关键结果：COL10A1在泛癌肿瘤组织中高表达，与EMT、TGF-β等促肿瘤通路及M2巨噬细胞浸润正相关，COL10A1+Fib在泛癌中富集且功能保守（促转移、免疫抑制）。</span></span></p><section><span><span leaf="">讨论</span></span></section><h4 data-pm-slice="0 0 []"><span leaf="">1. </span><strong><span leaf="">临床价值</span></strong></h4><ul><li><p><span leaf="">为CRC（尤其是CMS4亚型）的免疫治疗抵抗提供了新的机制解释。</span></p></li><li><p><span leaf="">COL10A1⁺ Fib可作为预后标志物和潜在治疗靶点。</span></p></li><li><p><span leaf="">NU7441作为老药新用，为靶向CAF的联合治疗提供新思路。</span></p></li></ul><h4><span leaf="">2. </span><strong><span leaf="">技术亮点</span></strong></h4><ul><li><p><strong><span leaf="">多组学整合</span></strong><span leaf="">：结合单细胞、空间、批量与蛋白数据，系统解析CAF异质性。</span></p></li><li><p><strong><span leaf="">空间转录组应用</span></strong><span leaf="">：揭示细胞间空间互作与微环境结构。</span></p></li><li><p><strong><span leaf="">机制闭环验证</span></strong><span leaf="">：从识别亚群→功能机制→反馈环路→药物干预，形成完整证据链。</span></p></li><li><p><strong><span leaf="">泛癌分析</span></strong><span leaf="">：拓展了研究结论的普适性与转化潜力。</span></p></li></ul><ul></ul><section data-pm-slice="9 11 []"><section data-pm-slice="3 3 []"><p><span leaf=""><span textstyle="">参考文献：</span></span><span data-pm-slice="0 0 []"><span leaf="">Hu S, Ding M, Lou J, Qin J, Chen Y, Liu Z, Li Y, Nie J, Xu M, Sun H, Gu X, Xu T, Wang S, Wang S, Pan Y. COL10A1</span></span><sup><span leaf="">+</span></sup><span><span leaf=""> fibroblasts promote colorectal cancer metastasis and M2 macrophage polarization with pan-cancer relevance. J Exp Clin Cancer Res. 2025 Aug 18;44(1):243. doi: 10.1186/s13046-025-03510-8. </span></span></p></section></section><p><mp-style-type data-value="10000"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/8yyPVYpZrPje7X7YQgmP-w",target="_blank" rel="noopener noreferrer">原文链接</a>
